Evidence map›Paper›PMID 40233961›Full record

ArticleBMJ open2025

Interplay of health-related quality of life and comorbidities in people with type 2 diabetes mellitus treated in primary care settings in Austria: a countrywide cross-sectional study.

Harald Sourij, Kehkishan Azhar, Faisal Aziz, Harald Kojzar, Caren Sourij, Peter Fasching, Martin Clodi, Bernhard Ludvik, Julia K Mader, Michael Resl and 7 more

Abstract read
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Harald Sourij *Interdisciplinary Metabolic Medicine Trials Unit, Medical University of Graz, Graz, Austria ha.sourij@medunigraz.at.ORCID http://orcid.org/0000-0003-3510-9594
Kehkishan Azhar *Interdisciplinary Metabolic Medicine Trials Unit, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0009-0007-8941-1728
Faisal AzizInterdisciplinary Metabolic Medicine Trials Unit, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0002-0109-2969
Harald KojzarInterdisciplinary Metabolic Medicine Trials Unit, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0002-9742-439X
Caren SourijInterdisciplinary Metabolic Medicine Trials Unit, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0003-1688-4026
Peter FaschingDivision of Endocrinology, Rheumatology and Acute Geriatrics, Clinic Ottakring, Vienna, Austria.ORCID http://orcid.org/0000-0003-1709-1079
Martin ClodiClinical Division of Internal Medicine, Saint John of God Hospital Linz, Linz, Austria.
Bernhard LudvikDepartment of Internal Medicine, Metabolic Diseases Landstrasse Clinic, Vienna, Austria.ORCID http://orcid.org/0009-0003-8717-8396
Julia K MaderDepartment of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0001-7854-4233
Michael ReslClinical Division of Internal Medicine, Saint John of God Hospital Linz, Linz, Austria.
Gersina Rega-KaunDivision of Endocrinology, Rheumatology and Acute Geriatrics, Clinic Ottakring, Vienna, Austria.ORCID http://orcid.org/0000-0002-3110-481X
Claudia RessDepartment of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria.
Lars StechemesserDepartment of Internal Medicine, Paracelsus Medical University, Salzburg, Austria.
Harald StinglDepartment of Internal Medicine, Hospital Mödling, Mödling, Austria.
Norbert Joachim TripoltInterdisciplinary Metabolic Medicine Trials Unit, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0002-7566-2047
Thomas WascherDepartment of Medicine, Hanusch Hospital, Vienna, Austria.
Susanne KaserDepartment of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria.ORCID http://orcid.org/0000-0003-2524-5218

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study assessed the health-related quality of life (HRQoL) and its relationship with clinical factors and comorbidities in people with type 2 diabetes mellitus (T2DM) treated in primary care settings.

designCross-sectional study design: This study assessed the HRQoL using a 36-item Short Form Survey (SF-36) tool in eight domains. The HRQoL scores ranged from 0% to 100% for each domain, with higher scores indicating better HRQoL. Linear regression was used to assess the association of HRQoL domain scores with clinical covariates and comorbidities.

settingA countrywide study was conducted on individuals with established T2DM (N=635) attending primary healthcare services for various conditions across nine federal states of Austria from 2021 to 2023.

participantsA total of 635 individuals, aged above 50 years and diagnosed with T2DM, were recruited by the attending physician to evaluate their HRQoL in relation to T2DM and its associated comorbidities.

resultsThe mean SF-36 scores for physical functioning (69±28), role-physical (62±42), mental health (72±20), role-emotional (73±41), social functioning (79±25), bodily pain (67±28) and vitality (55±22) were satisfactory, except for general health (41±10). Age and body mass were inversely associated with physical, mental and social HRQoL (p<0.05). Women had lower mental health (β: -5.44 [95% CI -9.43 to -1.44], p<0.05) than men. Smokers and those with cardiovascular and chronic lung diseases reported worse general, mental and physical health and vitality (p<0.05 each). Depression (p<0.001) and multimorbidity (p<0.05) severely deteriorated all HRQoL domains: physical functioning (Depression:-25.34 [95% CI -33.84 to -16.84], p<0.001); (Multimorbidity: -19.37 [95% CI -26.30 to -12.44], p<0.001), physical role limitations (-22.96 [95% CI -36.65 to -9.27], p<0.001); (-18.53 [95% CI -29.59 to -7.48], p<0.001), social functioning (-24.38 [95% CI -32.41 to -16.35], p<0.001); (-8.86 [95% CI -15.66 to -2.07], p<0.05), emotional well-being (-19.80 [95% CI -26.22 to -13.38], p<0.001); (-9.54 [95% CI -14.95 to -4.13], p<0.001), emotional role limitations (-28.26 [95% CI -41.01 to -15.52], p<0.001); (-8.15 [95% CI -18.78 to 2.49], p=0.133), bodily pains (-23.09 [95% CI -32.21 to -13.97], p<0.001); (-14.52 [95% CI -22.08 to -6.95], p<0.001), fatigue (-16.47 [95% CI -23.40 to -9.55], p<0.001); (-13.71 [95% CI -19.39 to -8.03], p<0.001), general health (-7.09 [95% CI -10.40 to -3.78], p<0.001); (-7.14 [95% CI -9.83 to -4.46], p<0.001).

conclusionsOur analysis showed that advanced age, obesity, depression, cardiovascular disease, chronic lung diseases and multimorbidity were associated with poor HRQoL of individuals with T2DM at the primary care level. These findings highlight the need for strengthening holistic management in primary care to address the diverse physical, social and emotional needs of individuals with T2DM.

Indexed as

Diabetes Mellitus, Type 2Primary Health CareQuality of LifeAgedAustriaComorbidityCross-Sectional StudiesFemaleHumansMaleMiddle AgedDiabetes Mellitus, Type 2MultimorbidityPrimary Health CareQuality of Life

Identifiers

PMID40233961
PMCPMC12001361

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.